Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Feb;141(4):549-51.
doi: 10.1038/sj.bjp.0705658. Epub 2004 Jan 26.

Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs

Affiliations

Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24 h after oral administration in dogs

Orsolya Nagy et al. Br J Pharmacol. 2004 Feb.

Abstract

Sildenafil (Viagra) prolongs repolarisation in cardiac muscle, an effect that could lead to ventricular fibrillation (VF). Sildenafil (2 mg kg(-1)) was given by mouth to 12 mongrel dogs and, 24 h later, these dogs were anaesthetised, thoracotomised and subjected to a 25 min occlusion of the anterior descending coronary artery. Haemodynamic parameters were similar in this and the control group, but there were fewer and less serious ventricular arrhythmias during occlusion in the sildenafil group (VF 17 vs 60%; ventricular premature beats 140+/-52 vs 437+/-127% and episodes of ventricular tachycardia 4.0+/-3.2 vs 19.3+/-7.7%, all P<0.05). However, reperfusion VF and indices of ischaemia severity (epicardial ST-segment mapping, inhomogeneity) were not modified by the drug. Sildenafil increased the QT interval, especially during ischaemia. Our conclusion is that ischaemia-induced ventricular arrhythmias are reduced by sildenafil, but this protection is less pronounced than that following cardiac pacing or exercise.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) The distribution of ventricular arrhythmias during a 25-min coronary artery occlusion and (b) the total number of VPBs, the incidence and the number of episodes of VT, and the incidence of VF in control dogs and in dogs treated with sildenafil. Values are means±s.e.m. *P<0.05 compared with controls. The severity of arrhythmias is less marked in the sildenafil-treated dogs.

References

    1. BABAI L., SZIGETI Z., PARRATT J.R., VÉGH Á. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible role of nitric oxide. Clin. Sci. 2002;102:435–445. - PubMed
    1. CHEITLIN M.D., HUTTER A.M., BRINDIS R.G., GANZ P., KAUL S., RUSSELL R.O., ZUSMAN R.M. Use of sildenafil (Viagra) in patients with cardiovascular disease. J. Am. Coll. Cardiol. 1999;33:273–282. - PubMed
    1. GEELEN P., DROLET B., RAIL J., BERUBE J., DALEAU P., ROUSSEAU G., CARDINAL R., O'HARA G.E., TURGEON J. Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation. 2000;102:275–277. - PubMed
    1. GRESSER U., GLEITER C.H. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil. Review of the literature. Eur. J. Med. Res. 2002;7:435–446. - PubMed
    1. KIS A., VÉGH Á., PAPP J.G., PARRATT J.R. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. Br. J. Pharmacol. 1999;127:1545–1550. - PMC - PubMed

Publication types

MeSH terms